NCT01746849View on ClinicalTrials.gov

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
LeukemiaMultiple MyelomaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Interventions
BIOLOGICAL

Palifermin

BIOLOGICAL

Lupron

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

Total-Body Irradiation (TBI)

DRUG

Thiotepa

DRUG

Cyclophosphamide

DRUG

Degarelix

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Swedish Orphan Biovitrum
All Listed Sponsors
collaborator

Swedish Orphan Biovitrum

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER